Next generation products for wound management

World Wide Wounds

Volumn 2002, Issue , 2002, Pages

  Stewart, Johanne ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bioactive dressings; Chronic wounds; New technology; Skin substitutes; Wound healing

Indexed keywords

ACTICOAT; ACTISORB SILVER 220; CADEXOMER IODINE; IODINE; SILVER DERIVATIVE;

ARTIFICIAL SKIN; COST EFFECTIVENESS ANALYSIS; HUMAN; PATIENT SATISFACTION; REVIEW; SKIN GRAFT; SPLIT THICKNESS SKIN GRAFT; TISSUE ENGINEERING; WOUND; WOUND CARE; WOUND DRESSING;

EID: 4043169902     PISSN: 13692607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Price RD, Das-Gupta V, Frame JD, Navsaria HA. A study to evaluate primary dressings for the application of cultured keratinocytes. Br J Plast Surg 2001; 54(8): 687-96.
2. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ 2002; 324(7330): 160-3.
3. Furr JR, Russell AD, Turner TD, Andrews A. Antibacterial activity of Actisorb Plus, Actisorb and silver nitrate. J Hosp Infect 1994; 27(3): 201-8.
4. Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil 1998; 19(6): 531-7.
5. Yin HQ, Langford R, Burrell RE. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 1999; 20(3): 195-200.
6. Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns 2001; 27(6): 621-7.
7. Thomas S. Alginate dressings in surgery and wound management - Part 1. J Wound Care 2000; 9(2): 56-60.
8. Skjak-Braek G, Flo T, Halaas O, et al. Immune stimulating properties of di-equatorially beta (1-4) linked polyuronides. In: Paulsen BS, editor. Bioactive Carbohydrate Polymers. The Netherlands: Kluwer Academic Publishers, 2000; 85-93.
9. Moore K, Thomas A, Harding KG. Iodine released from the wound dressing Iodosorb modulates the secretion of cytokines by human macrophages responding to bacterial lipopolysaccharide. Int J Biochem Cell Biol 1997; 29(1): 163-71.
10. Boyce DE, Jones WD, Ruge F, Harding KG, Moore K. The role of lymphocytes in human dermal wound healing. Br J Dermatol 2000; 143(1): 59-65.
11. Kitamura H, Kondo Y, Sakairi N, Nishi N. Preparation and characterization of antibacterial alginate film containing DNA as a carrier of silver ion. Nucleic Acids Symp Ser 1997; (37): 273-4.
12. Suzuki Y, Nishimura Y, Tanihara M, Suzuki K, Nakamura T, Shimizu Y, Yamawaki Y, Kakimaru Y. Evaluation of a novel alginate gel dressing: cytotoxicity to fibroblasts in vitro and foreign-body reaction in pig skin in vivo. J Biomed Mater Res 1998; 39(2): 317-22.
13. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Yamawaki Y, Kudo H, Kakimaru Y, Shimizu Y. In vivo evaluation of a novel alginate dressing. J Biomed Mater Res 1999; 48(4): 522-7.
14. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 1993; 101(1): 64-8.
15. Cullen B, Smith R, McCulloch E, Silcock D, Morrison L. Mechanism of action of PROMOGRAN, a protease modulating matrix, for the treatment of diabetic foot ulcers. Wound Repair Regen 2002; 10(1): 16-25.
16. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002; 137(7): 822-7.
17. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, Jensen J, Sabolinski M, Hardin-Young J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998; 134(3): 293-300.
18. Leigh IM, Purkis PE, Navsaria HA, Phillips TJ. Treatment of chronic venous ulcers with sheets of cultured allogeneic keratinocytes. Br J Dermatol 1987; 117(5): 591-7.
19. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999; 7(4): 201-7.
20. Kangesu T, Navsaria HA, Manek S, Fryer PR, Leigh IM, Green CJ. Kerato-dermal grafts: the importance of dermis for the in vivo growth of cultured keratinocytes. Br J Plast Surg 1993; 46(5): 401-9.
21. Boyce ST. Design principles for composition and performance of cultured skin substitutes. Burns 2001; 27(5): 523-33.
22. Shakespeare P. Burn wound healing and skin substitutes. Burns 2001; 27(5): 517-22.
23. Kearney JN. Clinical evaluation of skin substitutes. Burns 2001; 27(5): 545-51.
24. Burke JF, Yannas IV, Quinby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194(4): 413-28.
25. Heimbach D, Luterman A, Burke J, Bondoc CC, Cram A, Herndon D, Hunt J, et al. Artificial dermis for major burns. A multi-center randomized clinical trial . Ann Surg 1988; 208(3): 313-20.
26. Fitton AR, Drew P, Dickson WA. The use of a bilaminate artificial skin substitute (Integra) in acute resurfacing of burns: an early experience. Br J Plast Surg 2001; 54(3): 208-12.
27. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD. The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. J Burn Care Rehabil 1999; 20(6): 453-61.
28. Chan ES, Lam PK, Liew CT, Lau HC, Yen RS, King WW. A new technique to resurface wounds with composite biocompatible epidermal graft and artificial skin. J Trauma 2001; 50(2): 358-62.
29. Chu CS, McManus AT, Matylevich NP, Goodwin CW, Pruitt BA. Integra as a dermal replacement in a meshed composite skin graft in a rat model: a one-step operative procedure. J Trauma 2002; 52(1): 122-9.
30. Dantzer E, Braye FM. Reconstructive surgery using an artificial dermis (Integra): results with 39 grafts. Br J Plast Surg 2001; 54(8): 659-64.
31. Moiemen NS, Staiano JJ, Ojeh NO, Thway Y, Frame JD. Reconstructive surgery with a dermal regeneration template: clinical and histologic study. Plast Reconstr Surg 2001; 108(1): 93-103.
32. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995; 21(4): 243-8.
33. Wainwright D, Madden M, Luterman A, Hunt J, Monafo W, Heimbach D, Kagan R, Sittig K, Dimick A, Herndon D. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabil 1996; 17(2): 124-36.
34. Lattari V, Jones LM, Varcelotti JR, Latenser BA, Sherman HF, Barrette RR. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: a report of three cases. J Burn Care Rehabil 1997; 18(2): 147-55.
35. Barret JP, Dziewulski P, McCauley RL, Herndon DN, Desai MH. Dural reconstruction of a class IV calvarial burn with decellularized human dermis. Burns 1999; 25(5): 459-62.
36. Sheridan RL, Choucair RJ. Acellular allogeneic dermis does not hinder initial engraftment in burn resurfacing and reconstruction. J Burn Care Rehabil 1997; 18: 496-99.
37. Sheridan RL, Choucair RJ, Donelan M, Lydon RJ, Petras L, Tompkins R. Acellular allogeneic dermis in burn surgery: 1 year results of pilot trial. J Burn Care Rehabil 1998; 19: 528-46.
38. Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel RL, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 1991; 12(2): 243-8.
39. Hansbrough JF, Cooper ML, Cohen R, Spielvogel R, Greenleaf G, Bartel RL, Naughton G. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice. Surgery 1992; 111(4): 438-46.
40. Hansbrough JF, Dore C, Hansbrough WB. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds. J Burn Care Rehabil 1992; 13(5): 519-29.
41. Economou TP, Rosenquist MD, Lewis RW, Kealey GP. An experimental study to determine the effects of Dermagraft on skin graft viability in the presence of bacterial wound contamination. J Burn Care Rehabil 1993; 16(1): 27-30.
42. Eaglstein WH, Iriondo M, Laszlo K. A composite skin substitute (graftskin) for surgical wounds. A clinical experience. Dermatol Surg 1995; 21(10): 839-43.
43. Veves A, Falanga V, Armstrong DG, Sabolinski ML, The Apligraf Diabetic Foot Ulcer Study. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24(2): 290-5.
44. Long RE, Falabella AF, Valencia I, Eaglstein WH, Kirsner RS. Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf). Arch Dermatol 2001; 137(12): 1660-1.
45. Lam PK, Chan ES, To EW, Lau CH, Yen SC, King WW. Development and evaluation of a new composite Laserskin graft. J Trauma 1999; 47(5): 918-22.
46. Caravaggi C, Faglia E, dalla Paola L, et al. Tissue engineering in the treatment of diabetic foot ulcers. In: Abatangelo G, Wiegel E, editors. New Frontiers of Medical Science: Redefining hyaluronan. Amsterdam: Elsevier Science, 2000; 313-19.
47. Harding KG, Jones V, Price P. Topical treatment: which dressing to choose. Diabetes Metab Res Rev 2000; 16 Suppl 1: S47-50.
48. Ghatnekar O, Willis M, Persson U. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries. J Wound Care 2002; 11(2): 70-4.
49. Schonfeld WH, Villa KF, Fastenau JM, Mazonson PD, Falanga V. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers. Wound Repair Regen 2000; 8 (4): 251-7.
50. Mathias SD, Prebil LA, Boyko WL, Fastenau J. Health-related quality of life in venous leg ulcer patients successfully treated with Apligraf: a pilot study. Adv Skin Wound Care 2000; 13(2): 76-8.